Showing 361-370 of 868 results for "".
Melasma Treatments: A Review of Laser Therapies and the Integration of Reflectance Confocal Microscopy
https://practicaldermatology.com/topics/general-topics/melasma-treatments-a-review-of-laser-therapies-and-the-integration-of-reflectance-confocal-microscopy/21363/Reflectance confocal microscopy may play a role in melasma stratification and treatment assessment.COVID-19 and Psoriasis: Lessons from the Ongoing Pandemic
https://practicaldermatology.com/columns/clinical-focus-1/covid-19-and-psoriasis-lessons-from-the-ongoing-pandemic/23601/While unanswered questions remain, the data are generally positive for patients with psoriasis.Take 5: Directions in Skin Cancer Care
https://practicaldermatology.com/columns/take-5/take-5-directions-in-skin-cancer-care/21772/Here are intriguing new findings on skin cancer management with possible clinical impact.Everything Old Is New Again: Re-assessing IPL
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/everything-old-is-new-again-re-assessing-ipl/23013/Long-term IPL use may turn the tables on aging skin.Currents
https://practicaldermatology.com/topics/skin-cancer-photoprotection/currents/22968/Targeting MelanomaTake 5: Promising Developments in Vitiligo Research
https://practicaldermatology.com/columns/take-5/promising-developments-in-vitiligo-research/21924/New studies suggest therapeutic pearls for the management of vitiligo and highlight new approaches to understanding the disorder.The Molecular Era in Melanoma Treatment
https://practicaldermatology.com/topics/skin-cancer-photoprotection/the-molecular-era-in-melanoma-treatment/21296/Erythema Multiforme Major Due to Fluconazole: A Case Report
https://practicaldermatology.com/youngmd-connect/resident-resource-center/erythema-multiforme-major-due-to-fluconazole-a-case-report/23887/The Biosimilar Revolution: A Look at the Potential Impact
https://practicaldermatology.com/issues/april-2025/the-biosimilar-revolution-a-look-at-the-potential-impact/35596/With many biosimilars expected to gain regulatory approval in coming months and years, Practical Dermatology interviewed Collin Blattner, DO, FAAD—an editorial board member and double-board–certified dermatologist who owns Clearchoice Dermatology, which has 12 locations in Oregon and Washington—abouVitiligo: Oral and Topical JAKs Show Promise
https://practicaldermatology.com/topics/pigmentary-disorders/vitiligo-oral-and-topical-jaks-show-promise/23316/Early studies offer some hope for emerging therapies for repigmentation.